Related Experiment Videos
Interferon production during the course of Mycoplasma pneumoniae infection
T Nakayama1, S Sonoda, T Urano
1Department of Pediatrics, Keio University, School of Medicine, Tokyo, Japan.
Abstract:
In patients infected with Mycoplasma pneumoniae the development of interferon (IFN) was studied in nasopharyngeal secretions and sera. The production of IFN-gamma by lymphocytes was also investigated in response to M. pneumoniae antigen and mumps virus antigen. IFN-alpha was detected in 25 (61.0%) of 41 nasopharyngeal secretion samples and in 25 (59.5%) of 42 serum samples within 6 days after the onset of illness. IFN-alpha was significantly higher in nasopharyngeal secretions than in sera and a significant correlation was observed between the two. In most of the patients lymphocytes produced a larger amount of IFN-gamma in the convalescent stage than in the acute stage, when lymphocytes were stimulated with M. pneumoniae antigen. In some patients, however, lymphocytes did not produce IFN-gamma during the course of illness. Such lymphocytes, negative for IFN-gamma production in response to M. pneumoniae, produced IFN-gamma after the depletion of macrophages, and readdition of macrophages suppressed the production of IFN-gamma by lymphocytes. When lymphocytes were stimulated with heterogeneous antigen (mumps virus), they produced no IFN or a small amount of IFN in the acute stage of M. pneumoniae infection, and IFN production increased in the convalescent stage. Different mechanisms seem to work for homogeneous and heterogeneous antigens in the suppression of IFN production in M. pneumoniae infection.
Insights
Interferon-alpha was detected in respiratory secretions and blood during Mycoplasma pneumoniae infections. Lymphocyte interferon-gamma production varied, suggesting distinct immune responses to different antigens.
Area of Science:
- Immunology
- Virology
- Respiratory Medicine
Background:
- Mycoplasma pneumoniae infections can trigger complex immune responses.
- Interferons (IFNs) play a crucial role in antiviral immunity.
- Understanding IFN dynamics in M. pneumoniae infection is vital for managing respiratory illness.
Purpose of the Study:
- To investigate the development of interferon-alpha (IFN-alpha) in nasopharyngeal secretions and sera of patients with M. pneumoniae infection.
- To analyze interferon-gamma (IFN-gamma) production by lymphocytes in response to M. pneumoniae and mumps virus antigens.
- To explore the role of macrophages in modulating lymphocyte IFN-gamma production during M. pneumoniae infection.
Main Methods:
- Detection of IFN-alpha in nasopharyngeal secretions and sera using established assays.
- Stimulation of patient lymphocytes with M. pneumoniae and mumps virus antigens.
- Assessment of IFN-gamma production by lymphocytes in acute and convalescent stages.
- Macrophage depletion and repletion experiments to study their effect on IFN-gamma production.
Main Results:
- IFN-alpha was detected in over 60% of respiratory secretions and serum samples within six days of illness onset.
- IFN-alpha levels were significantly higher in secretions than sera, with a strong correlation between the two.
- Lymphocyte IFN-gamma production in response to M. pneumoniae antigen increased in the convalescent stage for most patients.
- Some patients showed suppressed IFN-gamma production, which was restored upon macrophage depletion, indicating a macrophage-mediated suppression mechanism.
- Lymphocytes produced minimal IFN in response to mumps virus antigen during the acute phase, with increased production in the convalescent phase.
Conclusions:
- IFN-alpha is a significant marker in the early stages of M. pneumoniae infection, detectable in both local secretions and systemic circulation.
- Macrophage activity appears to play a regulatory role in lymphocyte IFN-gamma response to M. pneumoniae.
- Distinct immune mechanisms govern the response to homologous (M. pneumoniae) and heterologous (mumps virus) antigens, influencing IFN production dynamics during infection.